{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:58:04Z","timestamp":1760785084238,"version":"3.40.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guangdong Major Project of Basic and Applied Basic Research","award":["2020B0301030005"],"award-info":[{"award-number":["2020B0301030005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00253-022-12010-0","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T09:02:43Z","timestamp":1655197363000},"page":"4511-4521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Design and characterization of a novel lytic protein against Clostridium difficile"],"prefix":"10.1007","volume":"106","author":[{"given":"Meng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zifeng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9908-1001","authenticated-orcid":false,"given":"Jufang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"issue":"Pt 9","key":"12010_CR1","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1099\/jmm.0.058719-0","volume":"62","author":"M Biazzo","year":"2013","unstructured":"Biazzo M, Cioncada R, Fiaschi L, Tedde V, Spigaglia P, Mastrantonio P, Pizza M, Barocchi MA, Scarselli M, Galeotti CL (2013) Diversity of Cwp loci in clinical isolates of Clostridium difficile. J Med Microbiol 62(Pt 9):1444\u20131452. https:\/\/doi.org\/10.1099\/jmm.0.058719-0","journal-title":"J Med Microbiol"},{"issue":"24","key":"12010_CR2","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1111\/febs.14310","volume":"284","author":"WJ Bradshaw","year":"2017","unstructured":"Bradshaw WJ, Kirby JM, Roberts AK, Shone CC, Acharya KR (2017) The molecular structure of the glycoside hydrolase domain of Cwp19 from Clostridium difficile. FEBS J 284(24):4343\u20134357. https:\/\/doi.org\/10.1111\/febs.14310","journal-title":"FEBS J"},{"issue":"1","key":"12010_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12079-017-0429-z","volume":"12","author":"WJ Bradshaw","year":"2018","unstructured":"Bradshaw WJ, Roberts AK, Shone CC, Acharya KR (2018) The structure of the S-layer of Clostridium difficile. J Cell Commun Signal 12(1):319\u2013331. https:\/\/doi.org\/10.1007\/s12079-017-0429-z","journal-title":"J Cell Commun Signal"},{"issue":"1","key":"12010_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5009\/gnl.2014.8.1.1","volume":"8","author":"KE Burke","year":"2014","unstructured":"Burke KE, Lamont JT (2014) Clostridium difficile infection: a worldwide disease. Gut Liver 8(1):1\u20136. https:\/\/doi.org\/10.5009\/gnl.2014.8.1.1","journal-title":"Gut Liver"},{"issue":"6","key":"12010_CR5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1177\/1060028018757446","volume":"52","author":"EB Chahine","year":"2018","unstructured":"Chahine EB (2018) The rise and fall of metronidazole for Clostridium difficile infection. Ann Pharmacother 52(6):600\u2013602. https:\/\/doi.org\/10.1177\/1060028018757446","journal-title":"Ann Pharmacother"},{"key":"12010_CR6","doi-asserted-by":"publisher","unstructured":"Collins J, Auchtung JM (2017) Control of Clostridium difficile infection by defined microbial communities. Microbiol Spectr 5(5), 10.1128\/microbiolspec.BAD-0009-2016. https:\/\/doi.org\/10.1128\/microbiolspec.BAD-0009-2016","DOI":"10.1128\/microbiolspec.BAD-0009-2016"},{"key":"12010_CR7","doi-asserted-by":"publisher","unstructured":"Cuenot E, Garcia-Garcia T, Douche T, Gorgette O, Courtin P, Denis-Quanquin S, Hoys S, Tremblay YDN, Matondo M, Chapot-Chartier MP, Janoir C, Dupuy B, Candela T, Martin-Verstraete I (2019) The Ser\/Thr kinase PrkC participates in cell wall homeostasis and antimicrobial resistance in Clostridium difficile. Infect Immun 87(8), e00005-19. https:\/\/doi.org\/10.1128\/IAI.00005-19","DOI":"10.1128\/IAI.00005-19"},{"issue":"Suppl","key":"12010_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/1469-0691.12418","volume":"20","author":"SB Debast","year":"2014","unstructured":"Debast SB, Bauer MP, Kuijper EJ (2014) European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 20(Suppl):2. https:\/\/doi.org\/10.1111\/1469-0691.12418","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"12010_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.15698\/mic2018.09.648","volume":"5","author":"I El Meouche","year":"2018","unstructured":"El Meouche I, Peltier J (2018) Toxin release mediated by the novel autolysin Cwp19 in Clostridium difficile. Microb Cell 5(9):421\u2013423. https:\/\/doi.org\/10.15698\/mic2018.09.648","journal-title":"Microb Cell"},{"issue":"Pt 7","key":"12010_CR10","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1099\/mic.0.026328-0","volume":"155","author":"V Eldholm","year":"2009","unstructured":"Eldholm V, Johnsborg O, Haugen K, Ohnstad HS, Havarstein LS (2009) Fratricide in Streptococcus pneumoniae: contributions and role of the cell wall hydrolases CbpD LytA and LytC. Microbiology (Reading) 155(Pt 7):2223\u20132234. https:\/\/doi.org\/10.1099\/mic.0.026328-0","journal-title":"Microbiology (Reading)"},{"key":"12010_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.anaerobe.2017.04.001","volume":"45","author":"TG Ferreira","year":"2017","unstructured":"Ferreira TG, Moura H, Barr JR, PilottoDomingues RMC, Ferreira EO (2017) Ribotypes associated with Clostridium difficile outbreaks in Brazil display distinct surface protein profiles. Anaerobe 45:120\u2013128. https:\/\/doi.org\/10.1016\/j.anaerobe.2017.04.001","journal-title":"Anaerobe"},{"issue":"13","key":"12010_CR12","doi-asserted-by":"publisher","first-page":"10460","DOI":"10.1074\/jbc.M111.336404","volume":"287","author":"MB Frankel","year":"2012","unstructured":"Frankel MB, Schneewind O (2012) Determinants of murein hydrolase targeting to cross-wall of Staphylococcus aureus peptidoglycan. J Biol Chem 287(13):10460\u201310471. https:\/\/doi.org\/10.1074\/jbc.M111.336404","journal-title":"J Biol Chem"},{"key":"12010_CR13","doi-asserted-by":"publisher","unstructured":"Garcia-Garcia T, Poncet S, Cuenot E, Douche T, Giai Gianetto Q, Peltier J, Courtin P, Chapot-Chartier MP, Matondo M, Dupuy B, Candela T, Martin-Verstraete I (2021) Ser\/Thr Kinase-dependent phosphorylation of the peptidoglycan hydrolase CwlA controls its export and modulates cell division in Clostridioides difficile. mBio 12(3), e00519-21. https:\/\/doi.org\/10.1128\/mBio.00519-21","DOI":"10.1128\/mBio.00519-21"},{"key":"12010_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1475-2859-12-67","volume":"12","author":"P Gatti-Lafranconi","year":"2013","unstructured":"Gatti-Lafranconi P, Dijkman WP, Devenish SRA, Hollfelder F (2013) A single mutation in the core domain of the lac repressor reduces leakiness. Microb Cell Fact 12:67. https:\/\/doi.org\/10.1186\/1475-2859-12-67","journal-title":"Microb Cell Fact"},{"issue":"2","key":"12010_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1574-6968.2011.02312.x","volume":"321","author":"M Gerova","year":"2011","unstructured":"Gerova M, Halgasova N, Ugorcakova J, Bukovska G (2011) Endolysin of bacteriophage BFK20: evidence of a catalytic and a cell wall binding domain. FEMS Microbiol Lett 321(2):83\u201391. https:\/\/doi.org\/10.1111\/j.1574-6968.2011.02312.x","journal-title":"FEMS Microbiol Lett"},{"issue":"2","key":"12010_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijmm.2013.11.006","volume":"304","author":"F Gotz","year":"2014","unstructured":"Gotz F, Heilmann C, Stehle T (2014) Functional and structural analysis of the major amidase (Atl) in Staphylococcus. Int J Med Microbiol 304(2):156\u2013163. https:\/\/doi.org\/10.1016\/j.ijmm.2013.11.006","journal-title":"Int J Med Microbiol"},{"key":"12010_CR17","doi-asserted-by":"publisher","unstructured":"Haddad Kashani H, Schmelcher M, Sabzalipoor H, Seyed Hosseini E, Moniri R (2018) Recombinant endolysins as potential therapeutics against antibiotic-resistant Staphylococcus aureus: current status of research and novel delivery strategies. Clin Microbiol Rev 31(1), e00071-17. https:\/\/doi.org\/10.1128\/CMR.00071-17","DOI":"10.1128\/CMR.00071-17"},{"issue":"1","key":"12010_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/1751-7915.12372","volume":"10","author":"JA Kirk","year":"2017","unstructured":"Kirk JA, Banerji O, Fagan RP (2017) Characteristics of the Clostridium difficile cell envelope and its importance in therapeutics. Microb Biotechnol 10(1):76\u201390. https:\/\/doi.org\/10.1111\/1751-7915.12372","journal-title":"Microb Biotechnol"},{"key":"12010_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.22203\/eCM.v039a06","volume":"39","author":"CC Lee","year":"2020","unstructured":"Lee CC, Southgate RD, Jiao C, Gersz E, Owen JR, Kates SL, Beck CA, Xie C, Daiss JL, Post V, Moriarty TF, Zeiter S, Schwarz EM, Muthukrishnan G (2020) Deriving a dose and regimen for anti-glucosaminidase antibody passive-immunisation for patients with Staphylococcus aureus osteomyelitis. Eur Cell Mater 39:96\u2013107. https:\/\/doi.org\/10.22203\/eCM.v039a06","journal-title":"Eur Cell Mater"},{"issue":"9","key":"12010_CR20","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJMoa1408913","volume":"372","author":"FC Lessa","year":"2015","unstructured":"Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, Wilson LE, Winston LG, Cohen JA, Limbago BM, Fridkin SK, Gerding DN, McDonald LC (2015) Burden of Clostridium difficile infection in the United States. N Engl J Med 372(9):825\u2013834. https:\/\/doi.org\/10.1056\/NEJMoa1408913","journal-title":"N Engl J Med"},{"key":"12010_CR21","doi-asserted-by":"publisher","unstructured":"Marinescu AR, Laza R, Musta VF, Cut TG, Dumache R, Tudor A, Porosnicu M, Lazureanu VE, Licker M (2021) Clostridium Difficile and COVID-19: general data, ribotype, clinical form, treatment-our experience from the largest infectious diseases hospital in western Romania. Medicina (Kaunas) 57(10), 1099. https:\/\/doi.org\/10.3390\/medicina57101099","DOI":"10.3390\/medicina57101099"},{"issue":"Pt 7","key":"12010_CR22","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1242\/jcs.114.7.1253","volume":"114","author":"BJ Mayer","year":"2001","unstructured":"Mayer BJ (2001) SH3 domains: complexity in moderation. J Cell Sci 114(Pt 7):1253\u20131263. https:\/\/doi.org\/10.1242\/jcs.114.7.1253","journal-title":"J Cell Sci"},{"issue":"19","key":"12010_CR23","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1128\/JB.00439-11","volume":"193","author":"MJ Mayer","year":"2011","unstructured":"Mayer MJ, Garefalaki V, Spoerl R, Narbad A, Meijers R (2011) Structure-based modification of a Clostridium difficile-targeting endolysin affects activity and host range. J Bacteriol 193(19):5477\u20135486. https:\/\/doi.org\/10.1128\/JB.00439-11","journal-title":"J Bacteriol"},{"issue":"1","key":"12010_CR24","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s42003-020-01405-2","volume":"3","author":"M Nega","year":"2020","unstructured":"Nega M, Tribelli PM, Hipp K, Stahl M, Gotz F (2020) New insights in the coordinated amidase and glucosaminidase activity of the major autolysin (Atl) in Staphylococcus aureus. Commun Biol 3(1):695. https:\/\/doi.org\/10.1038\/s42003-020-01405-2","journal-title":"Commun Biol"},{"issue":"1","key":"12010_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jiac.2019.07.005","volume":"26","author":"H Okumura","year":"2020","unstructured":"Okumura H, Fukushima A, Taieb V, Shoji S, English M (2020) Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: a network meta-analysis. J Infect Chemother 26(1):43\u201350. https:\/\/doi.org\/10.1016\/j.jiac.2019.07.005","journal-title":"J Infect Chemother"},{"issue":"15","key":"12010_CR26","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1007\/s00253-015-6443-2","volume":"99","author":"DC Osipovitch","year":"2015","unstructured":"Osipovitch DC, Therrien S, Griswold KE (2015) Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity. Appl Microbiol Biotechnol 99(15):6315\u201326. https:\/\/doi.org\/10.1007\/s00253-015-6443-2","journal-title":"Appl Microbiol Biotechnol"},{"issue":"Pt 10","key":"12010_CR27","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1099\/jmm.0.061028-0","volume":"62","author":"M Pastagia","year":"2013","unstructured":"Pastagia M, Schuch R, Fischetti VA, Huang DB (2013) Lysins: the arrival of pathogen-directed anti-infectives. J Med Microbiol 62(Pt 10):1506\u20131516. https:\/\/doi.org\/10.1099\/jmm.0.061028-0","journal-title":"J Med Microbiol"},{"issue":"33","key":"12010_CR28","doi-asserted-by":"publisher","first-page":"29053","DOI":"10.1074\/jbc.M111.259150","volume":"286","author":"J Peltier","year":"2011","unstructured":"Peltier J, Courtin P, El Meouche I, Lemee L, Chapot-Chartier MP, Pons JL (2011) Clostridium difficile has an original peptidoglycan structure with a high level of N-acetylglucosamine deacetylation and mainly 3\u20133 cross-links. J Biol Chem 286(33):29053\u201329062. https:\/\/doi.org\/10.1074\/jbc.M111.259150","journal-title":"J Biol Chem"},{"issue":"4","key":"12010_CR29","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/mmi.12212","volume":"88","author":"DL Popham","year":"2013","unstructured":"Popham DL (2013) Visualizing the production and arrangement of peptidoglycan in Gram-positive cells. Mol Microbiol 88(4):645\u2013649. https:\/\/doi.org\/10.1111\/mmi.12212","journal-title":"Mol Microbiol"},{"issue":"14","key":"12010_CR30","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1001\/jama.2019.3849","volume":"323","author":"K Rao","year":"2020","unstructured":"Rao K, Malani PN (2020) Diagnosis and treatment of Clostridioides (Clostridium) difficile infection in adults in 2020. JAMA 323(14):1403\u20131404. https:\/\/doi.org\/10.1001\/jama.2019.3849","journal-title":"JAMA"},{"issue":"10","key":"12010_CR31","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.ajic.2014.06.011","volume":"42","author":"KR Reveles","year":"2014","unstructured":"Reveles KR, Lee GC, Boyd NK, Frei CR (2014) The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001\u20132010. Am J Infect Control 42(10):1028\u20131032. https:\/\/doi.org\/10.1016\/j.ajic.2014.06.011","journal-title":"Am J Infect Control"},{"issue":"4","key":"12010_CR32","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/mmi.14636","volume":"115","author":"H Sekiya","year":"2021","unstructured":"Sekiya H, Tamai E, Kawasaki J, Murakami K, Kamitori S (2021) Structural and biochemical characterizations of the novel autolysin Acd24020 from Clostridioides difficile and its full-function catalytic domain as a lytic enzyme. Mol Microbiol 115(4):684\u2013698. https:\/\/doi.org\/10.1111\/mmi.14636","journal-title":"Mol Microbiol"},{"issue":"1","key":"12010_CR33","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1038\/s41598-021-84188-8","volume":"11","author":"FS Shariati","year":"2021","unstructured":"Shariati FS, Keramati M, Valizadeh V, Cohan RA, Norouzian D (2021) Comparison of E. coli based self-inducible expression systems containing different human heat shock proteins. Sci Rep 11(1):4576. https:\/\/doi.org\/10.1038\/s41598-021-84188-8","journal-title":"Sci Rep"},{"key":"12010_CR34","doi-asserted-by":"publisher","unstructured":"Spigaglia P (2022) Clostridioides difficile infection (CDI) during the COVID-19 pandemic. Anaerobe 74, 102518. https:\/\/doi.org\/10.1016\/j.anaerobe.2022.102518","DOI":"10.1016\/j.anaerobe.2022.102518"},{"issue":"5","key":"12010_CR35","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00253-012-4484-3","volume":"96","author":"P Szweda","year":"2012","unstructured":"Szweda P, Schielmann M, Kotlowski R, Gorczyca G, Zalewska M, Milewski S (2012) Peptidoglycan hydrolases-potential weapons against Staphylococcus aureus. Appl Microbiol Biotechnol 96(5):1157\u20131174. https:\/\/doi.org\/10.1007\/s00253-012-4484-3","journal-title":"Appl Microbiol Biotechnol"},{"key":"12010_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijid.2017.09.022","volume":"65","author":"KM Tamez-Torres","year":"2017","unstructured":"Tamez-Torres KM, Torres-Gonz\u00e1lez P, Leal-Vega F, Garc\u00eda-Alderete A, L\u00f3pez Garc\u00eda NI, Mendoza-Aguilar R, Galindo-Fraga A, Bobadilla-Del Valle M, Ponce de Le\u00f3n A, Sifuentes-Osornio J (2017) Impact of Clostridium difficile infection caused by the NAP1\/RT027 strain on severity and recurrence during an outbreak and transition to endemicity in a Mexican tertiary care center. Int J Infect Dis 65:44\u201349. https:\/\/doi.org\/10.1016\/j.ijid.2017.09.022","journal-title":"Int J Infect Dis"},{"key":"12010_CR37","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-micro-091014-104115","volume":"69","author":"CM Theriot","year":"2015","unstructured":"Theriot CM, Young VB (2015) Interactions between the gastrointestinal microbiome and Clostridium difficile. Annu Rev Microbiol 69:445\u2013461. https:\/\/doi.org\/10.1146\/annurev-micro-091014-104115","journal-title":"Annu Rev Microbiol"},{"issue":"1","key":"12010_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jsb.2010.06.016","volume":"172","author":"T Unger","year":"2010","unstructured":"Unger T, Jacobovitch Y, Dantes A, Bernheim R, Peleg Y (2010) Applications of the restriction free (RF) cloning procedure for molecular manipulations and protein expression. J Struct Biol 172(1):34\u201344. https:\/\/doi.org\/10.1016\/j.jsb.2010.06.016","journal-title":"J Struct Biol"},{"issue":"3","key":"12010_CR39","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.str.2016.12.018","volume":"25","author":"A Usenik","year":"2017","unstructured":"Usenik A, Renko M, Mihelic M, Lindic N, Borisek J, Perdih A, Pretnar G, Muller U, Turk D (2017) The CWB2 cell wall-anchoring module is revealed by the crystal structures of the Clostridium difficile cell wall proteins Cwp8 and Cwp6. Structure 25(3):514\u2013521. https:\/\/doi.org\/10.1016\/j.str.2016.12.018","journal-title":"Structure"},{"issue":"2","key":"12010_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1574-6976.2007.00094.x","volume":"32","author":"W Vollmer","year":"2008","unstructured":"Vollmer W, Blanot D, de Pedro MA (2008) Peptidoglycan structure and architecture. FEMS Microbiol Rev 32(2):149\u2013167. https:\/\/doi.org\/10.1111\/j.1574-6976.2007.00094.x","journal-title":"FEMS Microbiol Rev"},{"issue":"12","key":"12010_CR41","doi-asserted-by":"publisher","first-page":"7447","DOI":"10.1128\/AAC.01357-15","volume":"59","author":"Q Wang","year":"2015","unstructured":"Wang Q, Euler CW, Delaune A, Fischetti VA (2015) Using a novel lysin to help control Clostridium difficile infections. Antimicrob Agents Chemother 59(12):7447\u20137457. https:\/\/doi.org\/10.1128\/AAC.01357-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"12010_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nprot.2007.521","volume":"3","author":"I Wiegand","year":"2008","unstructured":"Wiegand I, Hilpert K, Hancock RE (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3(2):163\u2013175. https:\/\/doi.org\/10.1038\/nprot.2007.521","journal-title":"Nat Protoc"},{"key":"12010_CR43","doi-asserted-by":"publisher","unstructured":"Wydau-Dematteis S, El Meouche I, Courtin P, Hamiot A, Lai-Kuen R, Saubam\u00e9a B, Fenaille F, Butel M-J, Pons J-L, Dupuy B, Chapot-Chartier M-P, Peltier J (2018) Cwp19 is a novel lytic transglycosylase involved in stationary-phase autolysis resulting in toxin release in Clostridium difficile. mBio 9(3), e00648-18. https:\/\/doi.org\/10.1128\/mBio.00648-18","DOI":"10.1128\/mBio.00648-18"},{"issue":"9","key":"12010_CR44","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1111\/1462-2920.15529","volume":"23","author":"D Zhu","year":"2021","unstructured":"Zhu D, Patabendige H, Tomlinson BR, Wang S, Hussain S, Flores D, He Y, Shaw LN, Sun X (2021) Cwl0971, a novel peptidoglycan hydrolase, plays pleiotropic roles in Clostridioides difficile R20291. Environ Microbiol 23(9):5222\u20135238. https:\/\/doi.org\/10.1111\/1462-2920.15529","journal-title":"Environ Microbiol"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-022-12010-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-022-12010-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-022-12010-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:18:54Z","timestamp":1744201134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-022-12010-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["12010"],"URL":"https:\/\/doi.org\/10.1007\/s00253-022-12010-0","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"type":"print","value":"0175-7598"},{"type":"electronic","value":"1432-0614"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"21 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}